These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30802699)

  • 41. HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients.
    Wang P; Lv Q; Mao Y; Zhang C; Bao C; Sun H; Chen H; Yi Z; Cai W; Fang Y
    J Affect Disord; 2018 Mar; 228():222-228. PubMed ID: 29275155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetics and depression: return of the repressed.
    Dalton VS; Kolshus E; McLoughlin DM
    J Affect Disord; 2014 Feb; 155():1-12. PubMed ID: 24238955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response.
    Lopez JP; Kos A; Turecki G
    Curr Opin Psychiatry; 2018 Jan; 31(1):7-16. PubMed ID: 29076893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
    Gourion D
    Encephale; 2008 Jan; 34(1):73-81. PubMed ID: 18514154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder.
    Mohammad GS; Joca S; Starnawska A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenomic Clinical Support Tools for the Treatment of Depression.
    Baum ML; Widge AS; Carpenter LL; McDonald WM; Cohen BM; Nemeroff CB;
    Am J Psychiatry; 2024 Jul; 181(7):591-607. PubMed ID: 38685859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Omega-3 fatty acids for depression in adults.
    Appleton KM; Sallis HM; Perry R; Ness AR; Churchill R
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004692. PubMed ID: 26537796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response.
    Zhou L; Zhu Y; Chen W; Tang Y
    J Affect Disord; 2021 May; 286():80-86. PubMed ID: 33714174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment response classes in major depressive disorder identified by model-based clustering and validated by clinical prediction models.
    Paul R; Andlauer TFM; Czamara D; Hoehn D; Lucae S; Pütz B; Lewis CM; Uher R; Müller-Myhsok B; Ising M; Sämann PG
    Transl Psychiatry; 2019 Aug; 9(1):187. PubMed ID: 31383853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene × environment interactions in the prediction of response to antidepressant treatment.
    Klengel T; Binder EB
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder.
    Goud Alladi C; Etain B; Bellivier F; Marie-Claire C
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.
    Fabbri C; Porcelli S; Serretti A
    Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone deacetylases (HDACs) as therapeutic target for depressive disorders.
    Misztak P; Pańczyszyn-Trzewik P; Sowa-Kućma M
    Pharmacol Rep; 2018 Apr; 70(2):398-408. PubMed ID: 29456074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment.
    Lisoway AJ; Chen CC; Zai CC; Tiwari AK; Kennedy JL
    Schizophr Res; 2021 Jun; 232():112-124. PubMed ID: 34049235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.
    Powell TR; Smith RG; Hackinger S; Schalkwyk LC; Uher R; McGuffin P; Mill J; Tansey KE
    Transl Psychiatry; 2013 Sep; 3(9):e300. PubMed ID: 24002086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.